389819945-NANDA-I-2018-2020-pt-es-pdf

Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation.
Pediatrics. 2004; 114(1):297–316
Beachy JM. Investigating jaundice in the newborn. Neonatal Netw. 2007; 26(5):327–333
Bhutani VK, Johnson LH, Schwoebel A, Gennaro S. A systems approach for neonatal
hyperbilirubinemia in term and near-term newborns. J Obstet Gynecol Neonatal Nurs. 2006;
35(4):444–455
Blackburn S. Hyperbilirubinemia and neonatal jaundice. Neonatal Netw. 1995; 14(7): 15–25
Boyd S. Treatment of physiological and pathological neonatal jaundice. Nurs Times. 2004;
100(13):40–43
Cohen SM. Jaundice in the full-term newborn. Pediatr Nurs. 2006; 32(3):202–208
Gartner LM, Herschel M. Jaundice and breastfeeding. Pediatr Clin North Am. 2001;
48(2):389–399
Hillman N. Hyperbilirubinemia in the late preterm infant. Newborn Infant Nurs Rev. 2007;
7(2):91–94
Porter ML, Dennis BL. Hyperbilirubinemia in the term newborn. Am Fam Physician. 2002;
65(4):599–606, 613–614
2.4.5 Risco de síndrome do desequilíbrio metabólico
Aschbacher K, Kornfeld S, Picard M, et al. Chronic stress increases vulnerability to
diet-related abdominal fat, oxidative stress, and metabolic risk.
Psychoneuroendocrinology. 2014; 46:14–22
Babio N, Bulló M, Salas-Salvadó J. Mediterranean diet and metabolic syndrome: the
evidence. Public Health Nutr. 2009; 12 9A:1607–1617 Bergman M, Chetrit A, Roth J,
Dankner R. Dysglycemia and long-term mortality: observations from the Israel study of
glucose intolerance, obesity and hypertension. Diabetes Metab Res Rev. 2015;
31(4):368–375